Brief: Bora Pharmaceuticals Says Completes Management Takeover Of Upsher-Smith Laboratories After Merger
02/04/2024 01:00
April 2 (Reuters) - Bora Pharmaceuticals Co Ltd
6472.TW :
* SAYS COMPLETES MANAGEMENT TAKEOVER OF UPSHER-SMITH
LABORATORIES
AFTER MERGER
* SAYS MERGER MAKES WAY FOR COMPANY TO ENTER THE U.S.
MARKET,
MARKING ITS MOST SIGNIFICANT STRATEGIC MOVE SINCE THE COMPANY
WAS ESTABLISHED
Source text for Eikon: ID:nMOP9xxgqY
Further company coverage: 6472.TW
(Reporting by Faith Hung)
((faith.hung@thomsonreuters.com;))
Recent news on BORA PHARMACEUTICALS
See all newsAI shortens drug discovery to around 1 year in China, Insilico CEO says
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
Brief: Bora Pharmaceuticals & GSK Sign $250M Five Year Global Manufacturing Contract
Brief: Bora Pharmaceuticals Says Jan-Sept Net Profit T$2.65 Bln